Prognostic Significance of Combination of Preoperative Platelet Count and Neutrophil-Lymphocyte Ratio (COP-NLR) in Patients with Non-Small Cell Lung Cancer: Based on a Large Cohort Study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Significance of Combination of Preoperative Platelet Count and Neutrophil-Lymphocyte Ratio (COP-NLR) in Patients with Non-Small Cell Lung Cancer: Based on a Large Cohort Study
Authors
Keywords
Platelets, Non-small cell lung cancer, Blood counts, Lymphocytes, Neutrophils, Adjuvant chemotherapy, Fibrinogen, Inflammation
Journal
PLoS One
Volume 10, Issue 5, Pages e0126496
Publisher
Public Library of Science (PLoS)
Online
2015-05-08
DOI
10.1371/journal.pone.0126496
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer
- (2014) D J Pinato et al. BRITISH JOURNAL OF CANCER
- Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions
- (2014) Fei Guo et al. Journal of Hematology & Oncology
- Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients undergoing surgery for gastric cancer
- (2014) Mitsuru Ishizuka et al. JOURNAL OF SURGICAL ONCOLOGY
- Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer
- (2013) M Ishizuka et al. BRITISH JOURNAL OF CANCER
- Does interleukin-6 link explain the link between tumour necrosis, local and systemic inflammatory responses and outcome in patients with colorectal cancer?
- (2012) Graeme J.K. Guthrie et al. CANCER TREATMENT REVIEWS
- The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
- (2012) Donald C. McMillan CANCER TREATMENT REVIEWS
- Clinical Impact of Immune Microenvironment in Stage I Lung Adenocarcinoma: Tumor Interleukin-12 Receptor β2 (IL-12Rβ2), IL-7R, and Stromal FoxP3/CD3 Ratio Are Independent Predictors of Recurrence
- (2012) Kei Suzuki et al. JOURNAL OF CLINICAL ONCOLOGY
- Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients
- (2011) Basem Azab et al. ANNALS OF SURGICAL ONCOLOGY
- Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis
- (2011) Myriam Labelle et al. CANCER CELL
- Prognostic Immune Markers in Non–Small Cell Lung Cancer
- (2011) Kei Suzuki et al. CLINICAL CANCER RESEARCH
- Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio
- (2010) Imran Bhatti et al. AMERICAN JOURNAL OF SURGERY
- The Role of Inflammation in the Pathogenesis of Non-small Cell Lung Cancer
- (2010) Dermot S. O'Callaghan et al. Journal of Thoracic Oncology
- The platelet contribution to cancer progression
- (2010) N. M. BAMBACE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Clinical Significance of Tumor-Infiltrating Lymphocytes in Lung Neoplasms
- (2009) Enrico Ruffini et al. ANNALS OF THORACIC SURGERY
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The platelet proteome
- (2009) Lisa Senzel et al. CURRENT OPINION IN HEMATOLOGY
- Prognostic Significance of Host- and Tumor-Related Factors in Patients with Gastric Cancer
- (2009) Yasuhiko Mohri et al. WORLD JOURNAL OF SURGERY
- Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma
- (2008) Richard A. Smith et al. AMERICAN JOURNAL OF SURGERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More